BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10359345)

  • 1. Contact lens-induced infection--a new model of Candida albicans keratitis.
    O'Day DM; Head WS; Robinson RD; Yang R; Shetlar D; Wang MX
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1607-11. PubMed ID: 10359345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in virulence between two Candida albicans strains in experimental keratitis.
    O'Day DM; Head WS; Csank C; Shetlar DJ; Robinson RD; McCollum GW; Yang R; Zhu TL; Wang MX
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1116-21. PubMed ID: 10752949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of adherence and matrix metalloproteinases in growth patterns of fungal pathogens in cornea.
    Dong X; Shi W; Zeng Q; Xie L
    Curr Eye Res; 2005 Aug; 30(8):613-20. PubMed ID: 16109640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal virulence of Candida albicans strains deficient in Tup1-regulated genes.
    Jackson BE; Mitchell BM; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2535-9. PubMed ID: 17525181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal keratitis associated with contact lens wear after penetrating keratoplasty.
    Kremer I; Goldenfeld M; Shmueli D
    Ann Ophthalmol; 1991 Sep; 23(9):342-5. PubMed ID: 1741607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in development of keratomycosis after Candida inoculation in the central and peripheral cornea.
    Ishibashi Y; Kaufman HE; Kagawa S
    J Med Vet Mycol; 1986 Dec; 24(6):437-44. PubMed ID: 3553520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in response in vivo to amphotericin B among Candida albicans strains.
    O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
    Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
    Hiraoka T; Kaji Y; Wakabayashi T; Nanbu PN; Okamoto F; Oshika T
    Cornea; 2007 Apr; 26(3):336-42. PubMed ID: 17413962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally administered antifungal therapy for experimental keratomycosis.
    O'Day DM
    Trans Am Ophthalmol Soc; 1990; 88():685-725. PubMed ID: 2095036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the pathogenicities of Fusarium solani and Candida albicans in the rabbit cornea.
    Ishibashi Y; Kaufman HE; Kagawa S
    J Med Vet Mycol; 1986 Oct; 24(5):369-76. PubMed ID: 3537261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression affects the severity of experimental Fusarium solani keratitis.
    Wu TG; Keasler VV; Mitchell BM; Wilhelmus KR
    J Infect Dis; 2004 Jul; 190(1):192-8. PubMed ID: 15195260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of macrophages in experimental keratomycosis.
    Hu J; Wang Y; Xie L
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2087-94. PubMed ID: 19074808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The roles of gelatinases in pathological changes of fungal keratitis in experimental rabbits].
    Zhai HL; Xie LX; Dong XG
    Zhonghua Yan Ke Za Zhi; 2007 Sep; 43(9):817-22. PubMed ID: 18070528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Feasibilities of photodynamic therapy in the treatment of corneal mycotic lesions: an experimental study].
    Mamikonian VR; Balaian ML; Budzinskaia MV; Strakhovskaia MV; Fedorov AA; Loshchenov VB; Shevchik SA; Negrimovskiĭ VM; Iuzhakova OA; Kuz'min SG; Vorozhtsov GN
    Vestn Oftalmol; 2007; 123(5):25-8. PubMed ID: 18078054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus corneal virulence in a new topical model of infection.
    Hume EB; Dajcs JJ; Moreau JM; Sloop GD; Willcox MD; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2904-8. PubMed ID: 11687535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
    Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida keratitis after descemet stripping and automated endothelial keratoplasty.
    Koenig SB; Wirostko WJ; Fish RI; Covert DJ
    Cornea; 2009 May; 28(4):471-3. PubMed ID: 19411972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal colonization and infection in Boston keratoprosthesis.
    Barnes SD; Dohlman CH; Durand ML
    Cornea; 2007 Jan; 26(1):9-15. PubMed ID: 17198007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.